February 17, 2021

COLUMBUS, Ohio – The National Institutes of Health awarded The Ohio State University College of Medicine more than $160 million research funding in 2020, increasing its rank to #39 in the country.

According to an annual analysis compiled by Blue Ridge Institute for Medical Research, Ohio State College of Medicine NIH funding totals are up more than $22 million from 2019. This a record high for NIH research and development contracts.

“Ohio State is home to some of the brightest minds in medicine who are working to find innovative solutions to the toughest health care challenges by pursuing breakthroughs in research and treatment to improve people’s lives,” said Dr. Hal Paz, executive vice president and chancellor for health affairs at The Ohio State University and chief executive officer at The Ohio State University Wexner Medical Center. “These valuable research dollars will help our teams conduct groundbreaking research to advance discovery and achieve our ultimate goal of transforming patient care.”

Five Ohio State research programs are ranked in the top 25. Surgery is ranked #4 with $21 million. Physiology is ranked #10 with $13.8 million. Neuroscience and Emergency Medicine are both ranked #19 with $10 million and $1.2 million, respectively. Microbiology is ranked #25 with $11.9 million.

“In addition to these programs, Ohio State has a number of research areas that have made significant advancements in the rankings,” said Dr. Carol Bradford, dean of Ohio State College of Medicine. “The growth in funding enables our interdisciplinary teams of clinician-scientists, researchers, administrators, grant managers and more to make important discoveries to enhance health, extend life and reduce disability.”

When the United States encountered an unprecedented health crisis in the COVID-19 pandemic, Ohio State initiated 130 new projects in 2020 to explore tests and treatments for COVID-19. 

“This is only possible due to the innovative nature of our faculty and researchers and the NIH’s valuable support,” said Peter Mohler, chief scientific officer at Ohio State Wexner Medical Center, vice dean for research at Ohio State College of Medicine and director of the Dorothy M. Davis Heart and Lung Institute. “This rapid pace of discovery benefits patients in Ohio and across the country.”

Part of the U.S. Department of Health and Human Services, the NIH is the nation’s primary federal agency conducting and supporting basic, clinical and translational medical research.


Media Contact: Serena Smith, Wexner Medical Center Media Relations, Serena.Smith@osumc.edu


Share This Story